Literature DB >> 1637887

Frequency and DNA sequence of tal-1 rearrangement in children with T-cell acute lymphoblastic leukemia.

A Borkhardt1, R Repp, J Harbott, C Keller, F Berner, J Ritterbach, F Lampert.   

Abstract

Using nested polymerase chain reaction (PCR) a gene rearrangement named tal-1 deletion was found in five of 56 leukemic bone marrow samples from children with T-cell acute lymphoblastic leukemia (ALL). The DNA sequences of the PCR fragments consisted of the known conserved germline sequences in addition to short DNA insertions at the breakpoint region, which were different in each patient. Moreover, one patient was examined at diagnosis and at relapse 11 months later, revealing identical DNA sequences at the rearrangement site. The recombination site of the tal rearrangement therefore may be used as a genetic marker for detecting minimal residual disease in about 10% of T-cell ALL in childhood.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1637887     DOI: 10.1007/bf01695477

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  24 in total

1.  Polymerase chain reaction for detection of residual leukaemia.

Authors:  G J Morgan; T Hughes; J W Janssen; J Gow; A P Guo; J M Goldman; L M Wiedemann; C R Bartram
Journal:  Lancet       Date:  1989-04-29       Impact factor: 79.321

2.  7q32-q36 translocations in childhood T cell leukemia: cytogenetic evidence for involvement of the T cell receptor beta-chain gene.

Authors:  S C Raimondi; C H Pui; F G Behm; D L Williams
Journal:  Blood       Date:  1987-01       Impact factor: 22.113

3.  The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.

Authors:  A J Carroll; W M Crist; M P Link; M D Amylon; D J Pullen; A H Ragab; G R Buchanan; R S Wimmer; T J Vietti
Journal:  Blood       Date:  1990-09-15       Impact factor: 22.113

4.  Clinical significance of cytogenetic studies in childhood acute lymphoblastic leukemia: experience of the BFM trials.

Authors:  J Harbott; J Ritterbach; W D Ludwig; C R Bartram; A Reiter; F Lampert
Journal:  Recent Results Cancer Res       Date:  1993

5.  New M13 vectors for cloning.

Authors:  J Messing
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

6.  Detection of minimal residual disease in acute lymphoblastic leukemia by in vitro amplification of rearranged T-cell receptor delta chain sequences.

Authors:  T E Hansen-Hagge; S Yokota; C R Bartram
Journal:  Blood       Date:  1989-10       Impact factor: 22.113

Review 7.  Prognostic and biological importance of chromosome findings in acute lymphoblastic leukemia.

Authors:  L M Secker-Walker
Journal:  Cancer Genet Cytogenet       Date:  1990-10-01

8.  Detection of minimal residual disease in leukemic patients with the t(10;14)(q24;q11) chromosomal translocation.

Authors:  J Kagan; L R Finger; E Besa; C M Croce
Journal:  Cancer Res       Date:  1990-09-01       Impact factor: 12.701

9.  Acute leukaemia in bcr/abl transgenic mice.

Authors:  N Heisterkamp; G Jenster; J ten Hoeve; D Zovich; P K Pattengale; J Groffen
Journal:  Nature       Date:  1990-03-15       Impact factor: 49.962

10.  T-cell acute childhood lymphoblastic leukemia with chromosome 14 q 11 anomaly: a morphologic, immunologic, and cytogenetic analysis of 10 patients.

Authors:  F Lampert; J Harbott; J Ritterbach; W D Ludwig; C Fonatsch; D Schwamborn; B Stier; A Gnekow; V Gerein; B Stollmann
Journal:  Blut       Date:  1988-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.